Providers face rising administrative burdens as GLP-1 approvals near 100 percent, Definitive Healthcare projects

Providers face rising administrative burdens as GLP-1 approvals near 100 percent, Definitive Healthcare projects
GLP-1 authorizations surge to 100 percent

The proportion of GLP-1 prescriptions requiring prior authorization has soared from just 3-5 percent in 2020 to nearly 100 percent today, according to Definitive Healthcare.

This dramatic change is creating significant challenges for providers, patients, and pharmaceutical companies, intensifying the administrative workload and threatening timely access to essential therapies. Industry analysts note that prior authorization processes, often implemented as a cost-control measure by payers, are slowing the delivery of newer medications that have seen rapid growth. Definitive Healthcare stresses that stakeholders must adapt quickly to this new landscape to support patient outcomes and manage operational strain.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.